Skip to main content
Clinical Trials/IRCT2017021612949N3
IRCT2017021612949N3CompletedPhase 3

Studing the effects of Epigallocatechin Gallate supplementation on lipid profile, Insulin resistance, Oxidative stress and inflammatory factors in rs9939609 FTO gene variants in type 2 diabetic patients.

Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences0 sites92 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
92

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Men or women aged between 20 to 60 years old, Minimum 2 years experience in diabete. Exclusion criteria: Alcohol consumption; smoking; Pregnant and lactating women; injection insulin; Taking anti inflammatory drugs; Using nutrition supplements; Hormone Therapy; Patients with a history of hypothyroidism; renal failure.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice Chancellor for research of Ahvaz Jundishapur University of Medical Sciences

Similar Trials